mTORC1 inhibition for epilepsy in TSC: Feasibility in question

被引：1
|
作者：
Sparagana, Steven P. [1 ,2 ]
机构：
[1] Texas Scottish Rite Hosp Children, Div Neurol, Dallas, TX 75219 USA
[2] Univ Texas Southwestern Med Sch, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA
来源：
NEUROLOGY | 2016年 / 87卷 / 10期
关键词：
TUBEROUS SCLEROSIS COMPLEX; GIANT-CELL ASTROCYTOMAS; EVEROLIMUS;
D O I：
10.1212/WNL.0000000000003073
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Clinical signs and symptoms have been used to diagnose and define tuberous sclerosis complex (TSC), with the first description being that of the Vogt triad (epilepsy, intellectual disability, and facial angiofibromas).(1) The clinical criteria to diagnose TSC no longer include epilepsy and intellectual disability, and have been further expanded. Presence of a disease-causing mutation in TSC1 or TSC2 (the genes involved in TSC) is now included as an independent diagnostic criterion.(2</SUP)
引用
收藏
页码：974 / 975
页数：2
相关论文
共 50 条
  • [31] Rapamycin and mTORC1 Inhibition in the Mouse: Skin Cancer Prevention
    Athar, Mohammad
    Kopelovich, Levy
    CANCER PREVENTION RESEARCH, 2011, 4 (07) : 957 - 961
  • [32] Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma
    Dong, Pingping
    Wang, Xiaoxiao
    Liu, Longzi
    Tang, Wenqing
    Ma, Lijie
    Zeng, Wenjiao
    Sun, Shaoyang
    Zhang, Li
    Zhang, Ningping
    Shen, Xizhong
    Janssen, Harry L. A.
    Dong, Ling
    Zhang, Si
    Chen, She
    JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1446 - 1459
  • [33] Inhibition of mTORC1 renders cardiac protection against lipopolysaccharide
    Li, Xiang
    Jiang, Lijing
    Lin, Shenghui
    He, Yunfen
    Shen, Guofeng
    Cai, Zhenlin
    Ling, Meirong
    Ni, Jindi
    Zhang, Hao
    Zhang, Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 8432 - 8442
  • [34] THE EFFECT OF MTORC1 INHIBITION ON NAFLD AND SUBSEQUENT HCC DEVELOPMENT
    Umemura, A.
    Itoh, Y.
    Karin, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S170 - S170
  • [35] Investigating MTORC1 inhibition downstream of Apc loss in vivo
    Sansom, Owen J.
    CANCER RESEARCH, 2012, 72
  • [36] Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
    Gosis, Bridget S.
    Wada, Shogo
    Thorsheim, Chelsea
    Li, Kristina
    Jung, Sunhee
    Rhoades, Joshua H.
    Yang, Yifan
    Brandimarto, Jeffrey
    Li, Li
    Uehara, Kahealani
    Jang, Cholsoon
    Lanza, Matthew
    Sanford, Nathan B.
    Bornstein, Marc R.
    Jeong, Sunhye
    Titchenell, Paul M.
    Biddinger, Sudha B.
    Arany, Zoltan
    SCIENCE, 2022, 376 (6590) : 264 - +
  • [37] mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma
    Pleniceanu, Oren
    Omer, Dorit
    Azaria, Einat
    Harari-Steinberg, Orit
    Dekel, Benjamin
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (01): : 155 - 159
  • [38] G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
    Prentzell, Mirja Tamara
    Rehbein, Ulrike
    Sandoval, Marti Cadena
    De Meulemeester, Ann-Sofie
    Baumeister, Ralf
    Brohee, Laura
    Berdel, Bianca
    Bockwoldt, Mathias
    Carroll, Bernadette
    Chowdhury, Suvagata Roy
    von Deimling, Andreas
    Demetriades, Constantinos
    Figlia, Gianluca
    de Araujo, Mariana Eca Guimaraes
    Heberle, Alexander M.
    Heiland, Ines
    Holzwarth, Birgit
    Huber, Lukas A.
    Jaworski, Jacek
    Kedra, Magdalena
    Kern, Katharina
    Kopach, Andrii
    Korolchuk, Viktor, I
    van't Land-Kuper, Ineke
    Macias, Matylda
    Nellist, Mark
    Palm, Wilhelm
    Pusch, Stefan
    Pittol, Jose Miguel Ramos
    Reil, Michele
    Reintjes, Anja
    Reuter, Friederike
    Sampson, Julian R.
    Scheldeman, Chloe
    Siekierska, Aleksandra
    Stefan, Eduard
    Teleman, Aurelio A.
    Thomas, Laura E.
    Torres-Quesada, Omar
    Trump, Saskia
    West, Hannah D.
    de Witte, Peter
    Woltering, Sandra
    Yordanov, Teodor E.
    Zmorzynska, Justyna
    Opitz, Christiane A.
    Thedieck, Kathrin
    CELL, 2021, 184 (03) : 655 - +
  • [39] TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β
    Ogorek, Barbara
    Lam, Hilaire C.
    Khabibullin, Damir
    Liu, Heng-Jia
    Nijmeh, Julie
    Triboulet, Robinson
    Kwiatkowski, David J.
    Gregory, Richard I.
    Henske, Elizabeth P.
    HUMAN MOLECULAR GENETICS, 2018, 27 (09) : 1654 - 1663
  • [40] Ablation of TSC2 Enhances Mitochondrial Function Via Activation of mTORC1 in β Cells
    Koyanagi, Maki
    Kido, Yoshiaki
    Asahara, Shun-Ichiro
    Shigeyama, Yutaka
    Matsuda, Tomokazu
    Shibutani, Yuki
    Fuchita, Megumi
    Noda, Tetsuo
    Seino, Susumu
    Kasuga, Masato
    DIABETES, 2010, 59 : A91 - A91
12345